| When it comes to the field of medical research then | | | | further tests, saving time and money. The earlier a |
| there is a very thin line between success and failure. | | | | potential drug can be marked out as unsuitable then |
| Having an edge over competitors and keeping it, is | | | | the more time and money is saved. This is why the |
| the thing that many research companies strive for, | | | | use of biomarkers is increasing across the world, and |
| but not all achieve. Competition is high and anything | | | | more firms are bringing them into the laboratory. |
| that can give a company an angle to work with is | | | | While all businesses are understandably keen on |
| usually grasped with both hands. | | | | reducing wasted time and spend, this is most |
| The amounts of money that are involved in this | | | | important for small businesses involved in the medical |
| industry are quite staggering. Billions of pounds are | | | | research industry. It is the start-ups and incubator |
| spent on research every year and that is because | | | | companies that are usually running on the tightest of |
| the financial rewards for coming up with a | | | | budgets and therefore rely on positive results to |
| breakthrough are also considerable. But companies | | | | keep investors happy and increase their chances of |
| are always looking for ways to become more | | | | bringing in more venture capital funding. For these |
| efficient and make the most of the budget they | | | | types of firms, the use of biomarkers can be |
| have. No one wants to spend cash developing a drug | | | | essential as they strive to speed up the research |
| over a prolonged period of time, only to find out that | | | | process and cut costs where possible. |
| it is unusable months down the line. | | | | There is little doubt that biomarkers are having a |
| It is for this reason that a large number of companies | | | | profound effect on the medical research industry all |
| involved in the medical research industry are turning | | | | over the world, and this trend only looks set to |
| to biomarkers to help them cut costs and speed up | | | | continue. |
| the research process. The reasons for this are | | | | As more companies start to use a biomarkers |
| self-explanatory. Biomarkers have the ability to save | | | | database and realise the true potential of biomarker |
| time by letting researchers know early on in the | | | | research, it will undoubtedly have a major impact on |
| process whether a potential drug will be unsuitable. If | | | | the whole sector of medical research. |
| this happens then there is no need to conduct | | | | |